Sheen, Y. et al. 2022. Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis. Radiology and Oncology. 56, 2 (Jul. 2022), 185–197.